<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03740321</url>
  </required_header>
  <id_info>
    <org_study_id>80558721/237</org_study_id>
    <nct_id>NCT03740321</nct_id>
  </id_info>
  <brief_title>SRAE With Embospheres for Hemorrhoids.</brief_title>
  <official_title>Superior Rectal Artery Embolization With Tri-acryl Gelatin Particles for Treatment of Symptomatic Hemorrhoids: Safety and Efficacy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Eskisehir Osmangazi University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Eskisehir Osmangazi University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      In this study , safety and efficacy of superior rectal artery embolization with embospheres
      will be researched prospectively.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Symptomatic hemorrhoidal disease is a still important public health problem although there
      are many surgical and nonsurgical minimal invasive treatment methods. Treatment methods are
      not satisfactory or invasive in some percent of the patients. Superior rectal artery
      embolization(SRAE) for hemorrhoids is an adapted technique derived from Doppler-guided
      hemorrhoidal artery ligation (DGHAL). In this technique, the distal branches of the superior
      rectal artery arising from the inferior mesenteric artery is occluded endovascularly with
      coils. Its feasibility and safety were supported by articles. Collateralization and
      recurrence was seen following coil embolization. To prevent this , tri-acryl gelatin
      microspheres in 500-700 and 700-900 micrometers in size will be used. Safety and efficacy of
      embolization and using different sized particles will be evaluated.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Anticipated">December 1, 2018</start_date>
  <completion_date type="Anticipated">December 1, 2020</completion_date>
  <primary_completion_date type="Anticipated">December 1, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Blocked randomized, single blind, prospective study</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Incidence of procedure related mortality (safety)</measure>
    <time_frame>12 month</time_frame>
    <description>The mortality rate among the patients during 12 months related with interventional procedure.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Incidence of procedure related complications (safety)</measure>
    <time_frame>12 month</time_frame>
    <description>The morbidity rate among the patients during 12 months related with interventional procedure.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Incidence of the patients' being free of symptoms from hemorrhoidal disease (efficacy)</measure>
    <time_frame>12 month</time_frame>
    <description>The efficacy and clinical success of the procedure will be evaluated</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Technical success</measure>
    <time_frame>On the day of intervention</time_frame>
    <description>The rate of interventions that were performed successfully.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Recurrence</measure>
    <time_frame>3-6-12. months</time_frame>
    <description>Recanalization or collateralization of the previously embolized rectal arteries.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Embolization</condition>
  <condition>Hemorrhoids</condition>
  <arm_group>
    <arm_group_label>Embospheres 500-700 microns</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Intervention.Embolization with 500-700 micron particles will be performed with 1 ml vials. Embolization procedure will be continued with vials until the stasis in SRAE will be achieved. Procedure will be performed only one time.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Embospheres 700-900 microns</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Intervention.Embolization with 700-900 micron particles will be performed with 1 ml vials. Embolization procedure will be continued with vials until the stasis in SRAE will be achieved. Procedure will be performed only one time.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Embolization with tri-acryl gelatin (Embosphere) particles</intervention_name>
    <description>Left, right and posterior branches of superior rectal artery will be embolized with tri-acryl gelatin particles in 500-700 and 700-900 micrometers in size until homeostasis will be achieved.</description>
    <arm_group_label>Embospheres 500-700 microns</arm_group_label>
    <arm_group_label>Embospheres 700-900 microns</arm_group_label>
    <other_name>Embosphere</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with symptoms of hemorrhoidal disease

          -  Patients with written informed consent

          -  Patients refusing surgery or other interventional methods

          -  Patients with high risk for surgery

          -  Patients accepting follow ups

        Exclusion Criteria:

          -  Previous intervention

          -  Colorectal diseases other than hemorrhoids

          -  Patients with anal stenosis

          -  Patients with rectal prolapsus

          -  pregnant patients

          -  Patients with contraindications for technical steps or contrast usage.

          -  Patients do nor or could not give written informed consent
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Fahrettin Kucukay</last_name>
    <role>Study Chair</role>
    <affiliation>Eskisehir Osmangazi University, Faculty of Medicine, Department of Interventional Radiology</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Fahrettin Kucukay, Prof.</last_name>
    <phone>+905325875318</phone>
    <email>fkucukay@hotmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Eskisehir Osmangazi University, Faculty of Medicine, Department of Interventional Radiology</name>
      <address>
        <city>Eski≈üehir</city>
        <zip>26450</zip>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Fahrettin Kucukay, Prof.</last_name>
      <phone>+905325875318</phone>
      <email>fkucukay@hotmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <link>
    <url>https://www.merit.com/interventional-oncology-spine/embolotherapy/microspheres/embosphere-microspheres/</url>
    <description>Device descriptions, Instructions for use</description>
  </link>
  <results_reference>
    <citation>Zakharchenko A, Kaitoukov Y, Vinnik Y, Tradi F, Sapoval M, Sielezneff I, Galkin E, Vidal V. Safety and efficacy of superior rectal artery embolization with particles and metallic coils for the treatment of hemorrhoids (Emborrhoid technique). Diagn Interv Imaging. 2016 Nov;97(11):1079-1084. doi: 10.1016/j.diii.2016.08.002. Epub 2016 Aug 31.</citation>
    <PMID>27597728</PMID>
  </results_reference>
  <results_reference>
    <citation>Vidal V, Sapoval M, Sielezneff Y, De Parades V, Tradi F, Louis G, Bartoli JM, Pellerin O. Emborrhoid: a new concept for the treatment of hemorrhoids with arterial embolization: the first 14 cases. Cardiovasc Intervent Radiol. 2015 Feb;38(1):72-8. doi: 10.1007/s00270-014-1017-8. Epub 2014 Nov 4.</citation>
    <PMID>25366092</PMID>
  </results_reference>
  <results_reference>
    <citation>Vidal V, Louis G, Bartoli JM, Sielezneff I. Embolization of the hemorrhoidal arteries (the emborrhoid technique): a new concept and challenge for interventional radiology. Diagn Interv Imaging. 2014 Mar;95(3):307-15. doi: 10.1016/j.diii.2014.01.016. Epub 2014 Feb 28.</citation>
    <PMID>24589187</PMID>
  </results_reference>
  <results_reference>
    <citation>Galkin E. [X-ray endovascular embolization of the superior rectal artery: New potentialities in the surgical management of chronic hemorrhoids]. Vestn Rentgenol Radiol. 2001 Nov-Dec;(6):44-9. Russian.</citation>
    <PMID>11858033</PMID>
  </results_reference>
  <results_reference>
    <citation>Tradi F, Louis G, Giorgi R, Mege D, Bartoli JM, Sielezneff I, Vidal V. Embolization of the Superior Rectal Arteries for Hemorrhoidal Disease: Prospective Results in 25 Patients. J Vasc Interv Radiol. 2018 Jun;29(6):884-892.e1. doi: 10.1016/j.jvir.2018.01.778. Epub 2018 Apr 30.</citation>
    <PMID>29724519</PMID>
  </results_reference>
  <results_reference>
    <citation>Venturini M, De Nardi P, Marra P, Panzeri M, Brembilla G, Morelli F, Melchiorre F, De Cobelli F, Del Maschio A. Embolization of superior rectal arteries for transfusion dependent haemorrhoidal bleeding in severely cardiopathic patients: a new field of application of the &quot;emborrhoid&quot; technique. Tech Coloproctol. 2018 Jun;22(6):453-455. doi: 10.1007/s10151-018-1802-5. Epub 2018 May 24.</citation>
    <PMID>29797246</PMID>
  </results_reference>
  <results_reference>
    <citation>Primo Romaguera V, Gregorio Hern√°ndez A, Andreo Hern√°ndez L, de la Morena Valenzuela E. Selective embolization of the superior rectal artery: An alternative to hemorrhoid surgery? Cir Esp. 2018 Apr;96(4):239-241. doi: 10.1016/j.ciresp.2017.08.005. Epub 2017 Oct 14. English, Spanish.</citation>
    <PMID>29042023</PMID>
  </results_reference>
  <verification_date>November 2018</verification_date>
  <study_first_submitted>November 8, 2018</study_first_submitted>
  <study_first_submitted_qc>November 9, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">November 14, 2018</study_first_posted>
  <last_update_submitted>November 9, 2018</last_update_submitted>
  <last_update_submitted_qc>November 9, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">November 14, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Eskisehir Osmangazi University</investigator_affiliation>
    <investigator_full_name>Fahrettin Kucukay,MD</investigator_full_name>
    <investigator_title>Prof.Dr.</investigator_title>
  </responsible_party>
  <keyword>Hemorrhoids</keyword>
  <keyword>Superior rectal artery</keyword>
  <keyword>embolization</keyword>
  <keyword>microspheric particles</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hemorrhoids</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>July 15, 2017</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/21/NCT03740321/Prot_000.pdf</document_url>
    </provided_document>
  </provided_document_section>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

